Foley is pleased to be a Gold sponsor of the Sino-American Biomedical and Pharmaceutical Association (SABPA) 5th Annual Pacific Forum. The conference brings together entrepreneurs, scientists, investors, executives, and policy makers to promote life sciences and biotechnology alliances across the Pacific Rim, including the U.S. West coast, greater China region, and Singapore.
Foley Partner Stephen Bent will participate on a panel discussion on November 7th at 2:30 p.m. on “What is Your China Play – Doing Business in a Shifting Regulatory, Investment, and Economic Environment.”
For more information about the SABPA 5th Annual Pacific Forum, please visit the SABPA Web site.
People
Related Insights
14 June 2024
Events
Data Privacy & Information Security: The Evolving Regulatory Landscape & How Companies Are Dealing With It
Join the American Resort Development Association and the University of Florida Levin College of Law for a joint legal symposium on the issues facing the timeshare and hospitality industries.
24 April 2024
Legal News: Environmental
U.S. EPA Finalizes Designation of Two PFAS Chemicals as Hazardous Substances Under CERCLA
On April 19, the U.S. Environmental Protection Agency released its long-awaited final rule designating perfluorooctanoic acid and perfluorooctanesulfonic acid, including their salts and structural isomers, as “hazardous substances” under Section 102(a) of the Comprehensive Environmental Response, Compensation, and Liability Act.
24 April 2024
Foley Career Perspectives
Washington, D.C. Office Managing Partner David Sanders Offers Insights for Aspiring General Counsel
Foley’s clients entrust our firm to look beyond the law to deliver holistic business solutions for their most challenging problems.